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Colorectal  cancer  (CRC)  is  one  of the  leading  causes  of  cancer  morbidity  and mortality  in Western
countries.  One  of  the  risk  factors  for colorectal  tumorigenesis  is  vitamin  D  insufﬁciency.
The  aim  of this  study  was  to establish  whether  increasing  dietary  vitamin  D  intake  can  prevent  or  delay
development  of chemically  induced  preneoplastic  lesions  in  the  colon  of mice.
We  fed  six  weeks  old  female  C57BL/6  J mice  (n = 28)  with  increasing  vitamin  D3 concentrations  (100,
400,  1000,  2500,  5000  IU/kg  diet).  To  induce  dysplasia,  a preneoplastic  lesion,  we injected  mice with  the
carcinogen  azoxymethane  (10  mg/kg)  intraperitoneally,  followed  by  three  cycles  of  2% dextran  sodium
sulfate salt,  a tumor  promoter,  in  the  drinking  water.
To  test  our  hypothesis  that high  vitamin  D  intake  prevents  formation  of  preneoplastic  lesions,  we  have
investigated  the  effect  of increasing  dietary  vitamin  D  on  development  of  premalignant  colorectal  lesions,
serum 25-hydroxyvitamin  D3 (25-D3)  levels,  and  expression  of  renal  vitamin  D  system  genes.
Dietary vitamin  D  concentration  correlated  inversely  with  dysplasia  score  (Spearman’s  correlation
coefﬁcient,  :  −0.579,  p =  0.002)  and  positively  with  serum  25-D3 levels  (:  0.752,  p = 0.001).  Increasing
dietary  vitamin  D  concentration  beyond  1000  IU/kg  led to  no  further  increase  in circulating  25-D3 levels,
while the  dysplasia  score  leveled  out  at ≥2500  IU/kg  vitamin  D. High  dietary  vitamin  D  intake  led  to
increased  renal  mRNA  expression  of  the  vitamin  D catabolizing  enzyme  cyp24a1  (:  0.518,  p  = 0.005)  and
decreased  expression  of the  vitamin  D  activating  enzyme  cyp27b1  (:  −0.452,  p  = 0.016),  protecting  the
body  from  toxic  serum  levels  of  the  active  vitamin  D metabolite  1,25-dihydroxyvitamin  D3 (1,25-D3).
Our  data  showed  that  increasing  dietary  vitamin  D intake  is  able  to prevent  chemically  induced  pre-
neoplastic  lesions.  The  maximum  impact  was  achieved  when  the mice  consumed  more  than  2500  IU
Speci
vitamin D/kg  diet.
This  article  is  part  of  a  
. IntroductionColorectal cancer is one of the most common cancers, therefore,
ts primary and secondary prevention is of extreme importance [1].
here is evidence that vitamin D is an effective chemopreventive
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agent against colorectal cancer. While human interventional stud-
ies [2–6] are less conclusive regarding tumor protective effects of
vitamin D, animal studies [7–12] are more clear-cut.
High dietary vitamin D intake as well as treatment with 1,25-
dihydroxyvitamin D3 (1,25-D3) or its analogues led to fewer or
smaller tumors or even prevented formation of colonic tumors
in several rodent models. This effect was observed irrespective of
whether the tumor was  caused by nutrition (Western-style diet,
[7]), genetic risk factors (Apcmin/+ mice [8]), or was chemically
induced with azoxymethane (AOM)/dextran sulfate sodium salt
(DSS) [9,10], 1,2-dimethylhydrazine [11], or dexamethasone [12].
Using the active vitamin D metabolite, 1,25-D3, might cause hyper-
Open access under CC BY-NC-ND license.calcemia, therefore it is less useful in prevention strategies.
In the present study we investigated the effect of increased
dietary vitamin D intake on progress of colorectal lesions in a mouse
model of chemically induced colonic tumorigenesis. We  aimed
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Table 1
Primer pairs used in the qRT-PCR, oligonucleotide sequence 5′ → 3′ .
Primer Forward Reverse
cyp24a1 GAGTCCATGAGGCTTACCC GTGTATTCACCCAGAACGG
cyp27b1 GTGTTGAGATTGTACCCTGTG GGGAGACTAGCGTATCTTGG
eef12 AGAGCTACATTGAGGGGTACG GACTTGATGTGATTATACCAA-D.M. Hummel et al. / Journal of Steroid Bioch
o determine the lowest vitamin D concentration that is able to
revent or delay the development of premalignant lesions. Our
esults showed that increasing dietary vitamin D intake reduced
igniﬁcantly the dysplasia score in mice treated with AOM and
SS and this reduction correlated signiﬁcantly with serum 25-
ydroxyvitamin D3 (25-D3) levels.
. Materials and methods
.1. Animals
Six weeks old female1 C57BL/6 J mice (Charles River, Sulzfeld,
ermany) were housed in controlled environment in the animal
acility of the Institute of Pathophysiology and Allergy Research at
he Medical University of Vienna with a 12 h light–dark cycle. Living
onditions and experiments were conducted according to the Euro-
ean Union Regulations on Care and Use of Laboratory Animals.
he study was approved by the Ethics Committee of the Medical
niversity of Vienna (Nr. 66.009/0245-II/36/2010).
Upon arrival, the animals were separated into ﬁve diet groups
six mice per group) receiving AIN-93G diet containing 100,
00, 1000, 2500 or 5000 IU vitamin D3/kg diet (LASvendi, Soest,
ermany).
.2. Model of chemically induced tumorigenesis
After 2.5 weeks of acclimatization to the diet, 8.5 weeks old
ice were injected once with 10 mg/kg AOM (Sigma Aldrich, St.
ouis, MO,  USA) intraperitoneally (day 1) to induce tumorigenesis.
e treated the mice for three 4-day cycles (days: 5–8, 26–29, and
7–50) with 2% DSS (MP  Biomedicals, Solon, OH, USA) dissolved
n the drinking water as tumor promoter. On day 64, mice were
naesthetized, blood was  collected, centrifuged and the serum was
tored at −20 ◦C until analysis. Mice were killed by cervical disloca-
ion, kidneys were removed and immediately shock frozen in liquid
itrogen. The colon was removed, washed with ice-cold PBS and 4%
ormalin and rolled into a plane spiral (so-called Swiss roll [13]).
he Swiss rolls were ﬁxed in 4% buffered formalin, dehydrated, and
arafﬁn embedded.
.3. Serum parameters
Serum 25-D3 was determined using a chemiluminescence assay
IDS, iSYS 25(OH)D; Immunodiagnostic systems Ltd, Boldon, UK)
n an IDS-iSYS multi-discipline automated analyser. Within-day
oefﬁcients of variation were 5.5–12.1% and inter-day coefﬁcients
f variation were 8.9–16.9%, respectively.
Calcium was measured using the COBAS 8000 Modular Anal-
ser (F. Hoffmann-La Roche AG, Basel, Switzerland) according to
he manufacturer’s instructions.
.4. RNA extraction and reverse transcription (RT)
Total renal RNA was isolated with TRIzol reagent (Invitrogen,
rand Island, NY, USA) according to the manufacturer’s instruc-
ions. Integrity of the RNA was assessed on agarose gels by staining
ith Gel Red (Biotium, Hayward, CA, USA). 2 g of total RNA were
everse transcribed using RevertAid H Minus Reverse Transcrip-
ase and Random Hexamer Primers (Fermentas, Ontario, Canada)
s described before [14].
Quantitative real time RT-PCR (qRT-PCR) was  performed using
ower SYBR Green Master Mix  (Applied Biosystems, Carlsbad,
1 Male mice were much more sensitive to AOM, more than half of them died
hortly after AOM treatment.CGTAG
vdr GGATCTGTGGAGTGTGTGGAGACC CTTCATCATGCCAATGTCCAC
CA, USA) on the ABI StepOnePlus Real-Time PCR System (Applied
Biosystems) in duplicates. PCR conditions were 10 min 95 ◦C, 40
cycles of 15 s 95 ◦C and 60 ◦C 60 s. Relative expression of the target
genes was normalized to the expression of the housekeeping gene:
eukaryotic translation elongation factor 1  2 (eef12), set relative
to the calibrator, Mouse Colon Total RNA (Clontech, Mountain View,
CA, USA), and calculated with the Ct method. Primer sequences
are stated in Table 1.
2.5. Histological examination of colon sections
Sections (4 m)  of parafﬁn-embedded colons were stained with
Mayer’s Hematoxylin Solution and Eosin (Sigma Aldrich), and
images of whole sections were acquired using TissueFAXS 2.04
(TissueGnostics GmbH, Vienna, Austria). A pathologist identiﬁed
the dysplastic regions in the colon sections. The size of the areas
with low grade and high grade dysplasia were determined with
the HistoQuest software 3.03 (TissueGnostics GmbH), and calcu-
lated as percentage of the examined epithelial area. Dysplasia score
was  calculated based on the method established by Riddell et al.
[15]. In short, low grade dysplasia was  scored 2, high grade dyspla-
sia was scored 3. These scores were multiplied by the percentage
of the affected region of the examined epithelial area. Since the
use of Swiss roles enabled us to examine the cross-section of the
entire colon, and to distinguish between reactive changes and dys-
plasia with a high degree of accuracy, we  excluded the category
“indeﬁnite dysplasia” from our analysis. Detection of Ki67 positivity
was  performed on sections of parafﬁn-embedded colons as previ-
ously described [16]. Rabbit anti Ki67 (1:200, Novus Biologicals,
Littelton, CO, USA) was  used as the primary antibody and X-Cell
Plus HRP (Menarini, Florence, Italy) was  used as the detection sys-
tem. Whole slide images were scanned using a Scanscope® scanner
(Aperio, Vista, CA, USA). The Positive Pixel Count Algorithm of the
ImageScope software (Aperio) was  used to quantify the positive
signal.
2.6. Statistical analysis
We  calculated Spearman’s correlation coefﬁcient () with two-
tailed signiﬁcance levels and determined the medians, because
data were not normally distributed and the number of animals per
group was too small for group comparison analysis. Statistical anal-
ysis was performed using the SPSS statistics package, version 18.0,
graphs were made using GraphPadPrism 5.0.
3. Results
3.1. Effect of dietary vitamin D intake on AOM/DSS-mediated
tumorigenesis
Mice fed diets with low vitamin D concentrations (≤1000 IU/kg)
showed more and further progressed dysplastic regions in the colon
compared with mice fed high amounts of vitamin D (Figs. 1A and 2
and Supplementary Fig. 1).
In order to understand the impact of dietary vitamin D intake
and serum 25-D3 levels on AOM/DSS-induced tumorigenesis, we
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Table  2
Summary of Spearman’s correlation analysis.
cyp24a1 cyp27b1 25-D3 Low grade dysplasia Dysplasia score
Diet group Correlation coefﬁcient 0.518b −0.452a 0.752b −0.593b −0.579b
Sig. (2-tailed) 0.005 0.016 0.001 0.001 0.002
N  28 28 28 27 27
Serum 25-D3 Correlation coefﬁcient 0.313 −0.419a 1.0000 −0.666b −0.618b
Sig. (2-tailed) 0.105 0.026 28 0.001 0.001
N  28 28 27 27
a Correlation is signiﬁcant at the 0.05 level (2-tailed).
b Correlation is signiﬁcant at the 0.01 level (2-tailed).
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Fig. 1. High dietary vitamin D decreases dysplasia score and increases serum 25-D3
levels. (A) Effect of diets containing increasing amounts of vitamin D on dysplasia
score. Score was calculated by adding percentage of low dysplasia region multiplied
by  2 and percentage of high dysplasia regions multiplied by 3. Circles represent
colonic dysplasia scores of individual mice, horizontal lines represent median. (B)
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5ffect of vitamin D content of the diet on serum 25-D3 levels. Horizontal lines repre-
ent  median. Discontinous lines are the borders of vitamin D deﬁciency (<20 ng/ml),
nd  sufﬁciency (≥30 ng/ml).
etermined the size of low and high grade dysplasia, and calcu-
ated the dysplasia score. Due to the low sample size we were
ot able to perform group comparisons, however we assessed
he strength of the association among vitamin D intake or serum
5-D3 levels, and the size of dysplasia or the dysplasia score by
alculating Spearman‘s correlation coefﬁcient. Closer the value of
his coefﬁcient is to 1, the stronger the association is. Positive
alues indicate a direct association, negative values an inverse
orrelation.
In our study the average size of low grade dysplasia corre-
ated inversely with dietary vitamin D concentration (: −0.593,
 = 0.001) and serum 25-D3 levels (: −0.666, p = 0.001, Table 2).
egions of high grade dysplasia were only found in mice fed with
itamin D concentrations ≤1000 IU/kg. Dysplasia score calculation
evealed a clear decrease of dysplastic lesions in colons of mice fed
itamin D concentrations ≥2500 IU/kg compared with mice fed a
iet containing 100, 400 or 1000 IU vitamin D/kg (Fig. 1A). The dys-
lasia score showed negative correlation with dietary vitamin D
ig. 2. High dietary vitamin D prevents preneoplastic changes in colon of mice. Hemat
000  IU/kg and (B) colon with high grade dysplasia from a mouse fed 100 IU vitamin D/kg(: −0.579, p = 0.002) and serum 25-D3 levels (: −0.618, p = 0.001,
Table 2).
The expression of the proliferation marker Ki67 in the whole
colon section was  lower in mice fed with 100 IU/kg vitamin D com-
pared with other diet groups. However, a marked increase in Ki67
expression was  observed in all regions with high grade dysplasia
when compared with non-dysplasic regions of the same animal
(Fig. 3).
3.2. Effect of vitamin D intake on serum parameters in mice
treated with AOM/DSS
Serum 25-D3 concentration increased with increasing vitamin D
intake, reaching a plateau from 1000 IU vitamin D/kg diet onwards
(Fig. 1B). The reference values for serum 25-D3 in humans deﬁne
vitamin D deﬁciency as <20 ng/ml, levels between 21 and 29 ng/ml
as vitamin D insufﬁciency and >30 ng/ml as sufﬁciency [17]. Accord-
ing to these values, 83.3% of the mice receiving 100 IU vitamin D/kg
diet were vitamin D deﬁcient. One animal in this group (16.7%)
and two in the 400 IU/kg group (33.4%) were vitamin D insufﬁcient.
All the other animals could be considered to have adequate 25-D3
levels.
Serum calcium concentrations remained relatively stable and
did not correlate with serum 25-D3 levels (data not shown). Sys-
temic levels of the active 1,25-D3 are regulated by the kidneys;
therefore, we measured gene expression of the vitamin D acti-
vating enzyme 25-hydroxyvitamin D3 1-hydroxylase (cyp27b1),
the vitamin D degrading enzyme 1,25-hydroxyvitamin D3 24-
hydroxylase (cyp24a1), and the vitamin D receptor (vdr) by
qRT-PCR. High dietary vitamin D intake increased cyp24a1 (:
0.518, p = 0.005) and inhibited cyp27b1 (: −0.452, p = 0.016) gene
expression. Furthermore, cyp27b1 expression correlated nega-
tively with serum 25-D3 levels (: −0.419, p = 0.026, Fig. 4, Table 2).
The expression of vdr was not inﬂuenced either by diet or serum
25-D3 levels.
oxylin–Eosin staining of (A) normal colon of a mouse fed with a diet containing
 diet.
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Fig. 3. Ki67 protein expression is increased in dysplastic region compared with normal mucosa. Immunohistochemistry of a colon from a mouse fed with 100 IU/kg vitamin
D.  Proliferation marker Ki67 was highly expressed in dysplastic region (right panel) compared with the adjacent normal mucosa (left panel) of the same mouse.
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yp24a1  (A), cyp27b1 (B) and vdr (C) expression. Circles represent relative expressi
. Discussion
The aim of this study was to ﬁnd the appropriate (lowest)
ietary vitamin D level that would prevent formation of prema-
ignant lesions in a mouse model of chemically induced colonic
umorigenesis. To our knowledge this is the ﬁrst study investigat-
ng the effect of dose-dependency of vitamin D intake on preventing
OM/DSS-induced colonic tumorigenesis in mice. We  could show
nequivocally that increasing vitamin D intake was able to delay
ormation of chemically induced low grade preneoplastic lesions
nd even prevent development of high grade dysplasia in the colon.
e observed a very clear inverse correlation between dysplasia
core and higher vitamin D intake as well as serum 25-D3 levels.
ur data support the hypothesis that increasing vitamin D in the
iet has chemopreventive effects on chemically induced precur-
ors of colorectal tumors in mice. This effect seems to plateau at an
ntake of 2500 IU vitamin D/kg diet or higher.
The effect of vitamin D, its metabolites and vitamin D ana-
ogues on colonic tumorigenesis in mice was investigated in several
tudies, however, the results are contradictory. Majority of the
tudies that were not able to show any preventing or delaying
ffect of vitamin D and its analogues on colorectal tumorigenesis
sed vitamin D-sufﬁcient control groups. In these studies, con-
rol diets contained 1000 IU/kg vitamin D [18,19], a level that is
robably already chemopreventive. Our study, similar to the data
resented by Fleet et al. [20], shows that 1000 IU vitamin D/kg diet
rovides 25-D3 serum levels substantially higher than 30 ng/ml.
evertheless there were reports for the effectiveness of vitamin
 even compared with standard control diet, e.g. the study by
ichera et al. [9] showing that the 1,25-D3 analogue Ro26-2198
iven for 28 days reduced colonic dysplasia in mice even com-
ared with controls receiving standard AIN-76A chow containing
000 IU vitamin D/kg diet.t vdr expression. Effect of increasing vitamin D concentration in the diet on renal
individual mice, horizontal lines represent median.
In most of the studies demonstrating that high vitamin D
intake reduced colorectal tumorigenesis, the control diets con-
tained ≤500 IU vitamin D/kg diet [7,8,11]. In the study of Xu et al.,
Apcmin/+ mice were fed a vitamin D deﬁcient diet and then received
either 0.33 g/kg 1,25-D3, the same amount of the analogue QW,  or
the analogue BTW intraperitoneally three times a week. The num-
ber of aberrant crypt foci (ACF, a tumor precursor) as well as crypt
multiplicity were reduced in each of the three groups compared
with Apcmin/+ mice injected with vehicle only [8]. The forma-
tion of colonic tumors caused by the so-called new Western-style
diet (NWD, mimicking dietary habits of Western populations, e.g.
increased fat content, decreased vitamin D and calcium) could be
prevented by supplementing the NWD  with vitamin D (2300 IU/kg
diet instead of 110 IU/kg) and calcium (7000 mg/kg [7]). Similar
results were observed in a study by Mokady, who compared 1,2-
dimethylhydrazine (DMH)-caused colonic tumorigenesis in rats fed
either a stress diet (more calories, 500 IU/kg vitamin D, less calcium,
less phosphorus), or a stress diet supplemented with 2000 IU/kg
vitamin D. All DMH-treated rats developed colonic tumors, how-
ever, multiplicity of adenocarcinomas was  reduced signiﬁcantly in
the rats fed the vitamin D supplemented stress diet compared with
rats fed the stress diet alone [11].
The vitamin D concentration used in most laboratory rodent
chow (1000 IU/kg, corresponding to 500 IU/day intake in a
2000 kcal human diet) lies between the estimated average require-
ment (400 IU/day) and the recommended dietary allowance
(600 IU/day) of the Institute of Medicine [17,21]). In our study we
examined the effect of both lower (100 and 400 IU/kg) and higher
(2500 and 5000 IU/kg) vitamin D intake on colon tumorigenesis. It
is now accepted that the tumor preventive effect of high vitamin
D intake is hindered by low calcium intake. In our study the diet
contained 0.51% calcium, which should be enough to further the
tumor preventive effect of vitamin D.
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Fleet et al. [20] observed a steep curvilinear rise in serum
5-D3 levels in mice fed with increasing doses of vitamin D in
he diet. Interestingly, in our study serum 25-D3 levels increased
ith increasing vitamin D intake from 100 to 1000 IU/kg, but then
eached a plateau. Further increasing vitamin D intake to 2500 or
ven 5000 IU had no signiﬁcant effect on serum 25-D3 levels. This
bservation might be due to the effect of AOM and DSS on the
iver of the mice. Both substances are highly toxic and were shown
o impair liver function in rodents [22,23]. The liver is the main
rgan responsible for the synthesis of 25-D3 [24], therefore any
amage may  lead to lower circulating 25-D3 levels [25]. We  pre-
ume that the plateau seen in serum 25-D3 levels in mice receiving
1000 IU/kg vitamin D is a consequence of the incapability of the
iver to cope with higher vitamin D intakes, due to the damages
aused by AOM and DSS.
Enhancing vitamin D concentrations in the diet led to increased
enal cyp24a1 and decreased cyp27b1 gene expression. These
hanges are likely to result in a lower conversion rate of 25-D3 to the
ormonally active 1,25-D3 and in an enhanced degradation of both
5-D3 and 1,25-D3 [20]. Due to this negative feedback mechanism,
igh concentrations of serum 1,25-D3 are prevented.2 Changes in
yp24a1 and cyp27b1 expression and activity were described also
y Akeno et al., although in that study the vitamin D-deﬁcient diet
ontained less calcium and phosphorus than the sufﬁcient diet [12],
hich might have also affected renal gene expression. Dietary vita-
in  D had not affected vdr gene expression, conﬁrming data from
ther groups [12,20].
We  could show that dietary vitamin D intake higher than
500 IU/kg diet delayed formation of premalignant lesions, such
s colonic dysplasia, in mice. Based on our data we conclude that
erum 25-D3 levels higher than 65 ng/ml would be necessary to
elay or prevent colorectal tumorigenesis in a chemically induced
olon cancer model in mice. Whether this value can be translated
o humans is not clear as yet, but it suggests that for cancer pre-
ention the desirable serum 25-D3 levels are in the upper “normal”
eference range. Our study underlines the signiﬁcance of vitamin D
s a promising chemopreventive agent.
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